INSP Share Price Performance

INSP Community Fair Values

AN
AnalystConsensusTarget
Consensus Narrative from 15 Analysts
V System US Launch Will Increase Therapy Access
Key Takeaways The U.S. launch of the Inspire V system and expanded reimbursement are poised to enhance patient adoption, potentially boosting revenue and margins. Strengthening medical education with industry experts aims to increase accessibility and operational efficiency, enhancing capacity and potentially impacting long-term revenues.
US$210.73
FV
40.9% undervalued intrinsic discount
16.84%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
1 day ago author updated this narrative
AN
AnalystHighTarget
Consensus Narrative from 15 Analysts
Aging Populations And Digital Integration Will Expand Sleep Apnea Treatments
Key Takeaways The company’s product innovation and integration of digital tools are accelerating adoption, driving revenue growth, margin expansion, and operational efficiencies. Expanded reimbursement coverage and ongoing global market entry remove key adoption barriers, setting the stage for broader and more diversified long-term growth.
US$270.00
FV
53.9% undervalued intrinsic discount
19.73%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
8 days ago author updated this narrative
AN
AnalystLowTarget
Consensus Narrative from 15 Analysts
Mounting Sleep Apnea Costs Will Stall Progress Yet Spur Renewal
Key Takeaways Rising healthcare cost pressures, regulatory hurdles, and competition from lower-cost alternatives threaten Inspire’s revenue growth, pricing power, and international expansion opportunities. Heavy reliance on the flagship device exposes Inspire to revenue risks if alternative sleep apnea treatments gain traction or device outcomes disappoint stakeholders.
US$149.00
FV
16.4% undervalued intrinsic discount
16.35%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
8 days ago author updated this narrative

View all narratives

Recent INSP News & Updates

No updates

Inspire Medical Systems, Inc. Key Details

Last Reported Earnings

Mar 31, 2025

Next Reporting Earnings

Aug 04, 2025

Earnings per share (EPS): 2.25
Gross Margin: 84.65%
Net Profit Margin: 7.92%
Debt/Equity Ratio: 0%

View full report ›

Inspire Medical Systems, Inc. Competitors

View more competitors

About INSP

Founded: 2007
Employees: 1246
CEO: Timothy Herbert
WebsiteView website: www.inspiresleep.com

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

U.S. Market Performance

7 Days: -0.3%
3 Months: 14.2%
1 Year: 15.7%
Year to Date: 8.0%

In the last week, the market has been flat, with a notable exception in the Materials sector dropping 4.1%. Meanwhile, the market is actually up 16% over the past year. Earnings are forecast to grow by 15% annually. Market details ›

Who Will Win In The Age Of Agentic AI

Bailey Pemberton

July 2025

Companies across the globe are beginning to pay attention to agentic AI. It’s also a term you’re likely to hear a lot during earnings season. In fact, it came up 26 times during...

Last Week

Inspire Medical Systems Stock Price

INSP Share Price Performance

INSP Community Fair Values

V System US Launch Will Increase Therapy Access

Aging Populations And Digital Integration Will Expand Sleep Apnea Treatments

Mounting Sleep Apnea Costs Will Stall Progress Yet Spur Renewal